Equities Analysts Offer Predictions for InnovAge Q3 Earnings

InnovAge Holding Corp. (NASDAQ:INNV) – Equities researchers at William Blair boosted their Q3 2025 earnings per share (EPS) estimates for shares of InnovAge in a report issued on Tuesday, February 4th. William Blair analyst J. Haase now expects that the company will post earnings per share of ($0.01) for the quarter, up from their previous forecast of ($0.02). The consensus estimate for InnovAge’s current full-year earnings is ($0.06) per share. William Blair also issued estimates for InnovAge’s FY2025 earnings at ($0.15) EPS and FY2026 earnings at $0.08 EPS.

INNV has been the topic of a number of other research reports. JPMorgan Chase & Co. restated an “underweight” rating and issued a $5.00 price target on shares of InnovAge in a research report on Tuesday, December 17th. KeyCorp started coverage on InnovAge in a research report on Friday, October 11th. They issued a “sector weight” rating on the stock.

InnovAge Stock Performance

INNV stock opened at $3.22 on Friday. The company has a current ratio of 1.21, a quick ratio of 1.21 and a debt-to-equity ratio of 0.27. InnovAge has a fifty-two week low of $3.12 and a fifty-two week high of $6.69. The business’s fifty day moving average price is $4.01 and its two-hundred day moving average price is $5.21.

InnovAge (NASDAQ:INNV) last posted its quarterly earnings data on Tuesday, February 4th. The company reported ($0.10) earnings per share for the quarter. InnovAge had a negative return on equity of 5.68% and a negative net margin of 2.03%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. SG Americas Securities LLC acquired a new position in shares of InnovAge in the fourth quarter valued at approximately $43,000. JPMorgan Chase & Co. boosted its holdings in InnovAge by 191.5% in the third quarter. JPMorgan Chase & Co. now owns 24,687 shares of the company’s stock valued at $148,000 after acquiring an additional 16,217 shares during the last quarter. Barclays PLC boosted its holdings in InnovAge by 289.0% in the third quarter. Barclays PLC now owns 25,614 shares of the company’s stock valued at $154,000 after acquiring an additional 19,029 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in InnovAge by 3.9% in the third quarter. Charles Schwab Investment Management Inc. now owns 165,531 shares of the company’s stock valued at $993,000 after acquiring an additional 6,153 shares during the last quarter. Finally, State Street Corp boosted its holdings in InnovAge by 1.2% in the third quarter. State Street Corp now owns 344,905 shares of the company’s stock valued at $2,069,000 after acquiring an additional 4,218 shares during the last quarter. Institutional investors and hedge funds own 12.26% of the company’s stock.

About InnovAge

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.